Cannabis Science and Technology’s editor-in-chief will be hosting a special screening of the documentary Weed the People on January 8, 2019 at 7:30 p.m. The screening will be held at Cinemark Hazlet 12 in Hazlet, New Jersey.
The documentary was produced by Ricki Lake and Abby Epstein and has a score of 100% on Rotten Tomatoes. The film description is as follows:
"Cannabis has been off-limits to doctors and researchers in the US for the past 80 years, but recently scientists have discovered its anti-cancer properties. Armed with only these laboratory studies, desperate parents obtain cannabis oil from underground sources to save their children from childhood cancers. Weed the People follows these families through unchartered waters as they take their children’s survival into their own hands. Some of their miraculous outcomes beget the unsettling question at the heart of the film: If weed is truly saving lives, why doesn’t the government want people to access it?"
Tickets for the New Jersey screening must be purchased in advance by January 1, 2019. The event will only take place if enough tickets are sold and ticketholders will not be charged until the ticket threshold is met. For more information, to see the trailer, and to purchase tickets, please visit: https://www.tugg.com/events/weed-the-people-bzcx
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.